Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
Who We Are BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered
On behalf of a premier, market-leading law firm based in London, we are seeking experienced Senior Associates specialising in Construction, Infrastructure, Energy, and Planning & Environmental Law , with bespoke opportunities available for high-caliber lawyers on
On behalf of our client, a leading Irish Law Firm, we are seeking an ambitious, Irish or UK-qualified lawyer with 3 to 5 years PQE to join their growing Corporate M&A/Private Equity practice group based in
Amicus Therapeutics is a global, patient-dedicated biotechnology company focused on discovering, developing, and delivering high-quality medicines for people living with rare metabolic diseases. Position Summary The Vice President of Global Drug Safety is a senior leader responsible
A global biotechnology company in Marlow is seeking a Vice President of Global Drug Safety to lead their pharmacovigilance strategy for post-approval products. You will ensure compliance with regulatory requirements and mentor a high-performing team. The
This London-based Intellectual Property role is an opportunity for an ambitious lawyer with a minimum of 4 years PQE to advise leading global brands across sectors including luxury goods, technology, and sports. The successful candidate will
About BioMarin BioMarin is a leading rare disease biotechnology company focused on genetically defined conditions. Guided by our purpose to develop medicines that make a profound impact on people’s lives, our global teams have delivered a